GB1289096A - - Google Patents
Info
- Publication number
- GB1289096A GB1289096A GB1289096DA GB1289096A GB 1289096 A GB1289096 A GB 1289096A GB 1289096D A GB1289096D A GB 1289096DA GB 1289096 A GB1289096 A GB 1289096A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- oct
- treatment
- acid
- absorptionpromoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 208000020401 Depressive disease Diseases 0.000 abstract 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- 101100188552 Arabidopsis thaliana OCT3 gene Proteins 0.000 abstract 1
- 101100188555 Arabidopsis thaliana OCT6 gene Proteins 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 150000003840 hydrochlorides Chemical class 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 229960003512 nicotinic acid Drugs 0.000 abstract 1
- 235000001968 nicotinic acid Nutrition 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- 150000003014 phosphoric acid esters Chemical class 0.000 abstract 1
- 235000008164 pyridoxal Nutrition 0.000 abstract 1
- 239000011674 pyridoxal Substances 0.000 abstract 1
- 229960003581 pyridoxal Drugs 0.000 abstract 1
- 235000008151 pyridoxamine Nutrition 0.000 abstract 1
- 239000011699 pyridoxamine Substances 0.000 abstract 1
- 235000008160 pyridoxine Nutrition 0.000 abstract 1
- 239000011677 pyridoxine Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 229960004799 tryptophan Drugs 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4704268 | 1968-10-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1289096A true GB1289096A (enExample) | 1972-09-13 |
Family
ID=10443490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1289096D Expired GB1289096A (enExample) | 1968-10-03 | 1968-10-03 |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1289096A (enExample) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0007691B1 (en) * | 1978-07-31 | 1984-01-18 | Massachusetts Institute Of Technology | Compositions for use in decreasing appetite for calories as carbohydrates |
| GB2157561A (en) * | 1984-03-20 | 1985-10-30 | Egyt Gyogyszervegyeszeti Gyar | An injectable solution especially for treating ketosis |
| WO1987001590A1 (en) * | 1985-09-20 | 1987-03-26 | Stephen Neil Kreitzman | A composition and pack for use in the treatment of obesity |
| DE3912232A1 (de) * | 1989-04-11 | 1989-11-30 | Klosa Josef | Mittel gegen harninkontinenz |
| WO2008006485A1 (de) * | 2006-07-13 | 2008-01-17 | Beiersdorf Ag | Kosmetische oder dermatologische zubereitungen mit einem gehalt an folsäure und einem oder mehreren polyolen |
| EP2269649A3 (de) * | 2004-08-26 | 2011-08-10 | Merz Pharma GmbH & Co. KGaA | Ein Kapillar-Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung |
-
1968
- 1968-10-03 GB GB1289096D patent/GB1289096A/en not_active Expired
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0007691B1 (en) * | 1978-07-31 | 1984-01-18 | Massachusetts Institute Of Technology | Compositions for use in decreasing appetite for calories as carbohydrates |
| GB2157561A (en) * | 1984-03-20 | 1985-10-30 | Egyt Gyogyszervegyeszeti Gyar | An injectable solution especially for treating ketosis |
| WO1987001590A1 (en) * | 1985-09-20 | 1987-03-26 | Stephen Neil Kreitzman | A composition and pack for use in the treatment of obesity |
| DE3912232A1 (de) * | 1989-04-11 | 1989-11-30 | Klosa Josef | Mittel gegen harninkontinenz |
| EP2269649A3 (de) * | 2004-08-26 | 2011-08-10 | Merz Pharma GmbH & Co. KGaA | Ein Kapillar-Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung |
| WO2008006485A1 (de) * | 2006-07-13 | 2008-01-17 | Beiersdorf Ag | Kosmetische oder dermatologische zubereitungen mit einem gehalt an folsäure und einem oder mehreren polyolen |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT74270A (en) | Aqueous pharmaceutical preparations of g-csf with a long shelf life and process to prepare them | |
| GB1277153A (en) | N-phenylsulfamoyl and n-phenylsulfonyl-amino salicylic acids and their derivatives | |
| CA973554A (en) | 2,3,5,6-tetraaminopyridine and its acid salts and processes for its preparation | |
| GB975387A (en) | Multivitamin compositions | |
| GB1477624A (en) | Amino acid parenteral solution containing reducing sugar | |
| GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
| GB1202148A (en) | Pharmaceutical compositions | |
| AU472024B2 (en) | l-(3-CYANO-3, 3, DIPHENYLPROPYL)-4-PEHNYLPIP ERINE-4-CARBOXYLIC ACID DERIVATIVES | |
| IE56229B1 (en) | 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them | |
| GB1446584A (en) | Agent for deodorising and influencing perspiration | |
| GB1261989A (en) | 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same | |
| GB1181967A (en) | Novel Picoline Derivatives and a Method for the Production Thereof | |
| GB1246727A (en) | Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids | |
| IL59257A (en) | 6-(n-(cyclic amino-substituted methylene)amino)penicillanates and salts thereof,their production and pharmaceutical compositions containing them | |
| ES373657A1 (es) | Un procedimiento para la preparacion de derivados simetri- cos de di-hidrotriazina n-sustituidos. | |
| GB1195294A (en) | Improvements in or relating to Pharmaceutical Compositions | |
| GB1187546A (en) | Propanolamine derivatives | |
| ES369304A1 (es) | Procedimiento de preparacion de nuevos derivados nitrogena-dos de la metil-2 benzil-3 imidazo-3h (4,5-b) piridina. | |
| GB1351437A (en) | N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity | |
| AU461481B2 (en) | Pharmaceutically active new 1,3-amino-alcohol esters and their salts and a process for the preparation thereof | |
| GB1111433A (en) | A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions | |
| IE33519B1 (en) | Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process | |
| GB1454390A (en) | Nasal decongestants | |
| GB1259264A (enExample) | ||
| GB1217138A (en) | Pharmaceutical compositions based on derivatives of benzimidazole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PE20 | Patent expired after termination of 20 years |